Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker ORMP
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Sep 17, 2026 | ORMP Oramed Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Jun 30, 2026 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jun 30, 2026 | ORMP Oramed Pharmaceuticals Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Mar 31, 2026 | ORMP Oramed Pharmaceuticals Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Mar 31, 2026 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 20, 2026 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 14, 2026 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jan 14, 2026 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 7, 2026 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 31, 2025 | ORMP Oramed Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Dec 31, 2025 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Nov 17, 2025 | ORMP Oramed Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Nov 17, 2025 | ORMP Oramed Pharmaceuticals Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Nov 17, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 24, 2025 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 24, 2025 | ORMP Oramed Pharmaceuticals Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 24, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 24, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 6, 2025 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 21, 2025 | ORMP Oramed Pharmaceuticals Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Aug 21, 2025 | ORMP Oramed Pharmaceuticals Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Jul 23, 2025 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Jul 23, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| May 21, 2025 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 28, 2025 | ORMP Oramed Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Apr 28, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 3, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 27, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 11, 2025 | ORMP Oramed Pharmaceuticals Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Feb 11, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 22, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 3, 2025 | ORMP Oramed Pharmaceuticals Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 17, 2024 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2024 | ORMP Oramed Pharmaceuticals Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
34 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:06 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances